Reuters | Published: January 26, 2021 18:05:55 | Updated: January 28, 2021 10:49:01
Johnson & Johnson on Tuesday posted an 8.3 per cent rise in quarterly sales and said it would share details from its keenly watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.
Quarterly sales rose to $22.48 billion from $20.75 billion.
Strict monitoring can check price hike in Ramadan
Matarbari port to be ‘green, eco-friendly’
Curtain falls on int'l plastic fair
German shipping line launches new route from BD
Global suppliers queue up for exporting food grains
MCCI for not reducing subsidy on energy for at least one more year
IBBL Dhaka East & Central Zone hold agent banking conference
Syed M Omar Tayub promoted as DMD of Prime Bank
Air India to hire over 4,200 cabin crew, 900 pilots after record aircraft deal
© 2024 - All Rights with The Financial Express
